Mitsubishi Tanabe Pharma Corp operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mitsubishi Tanabe Pharma Corp with three other
companies in this sector in Japan:
Kyowa Hakko Kirin Company Limited
sales of 343.02 billion Japanese Yen [US$3.05 billion]
of which 77%
was Pharmaceutical Business),
Chugai Pharmaceutical Co Ltd
(491.78 billion Japanese Yen [US$4.37 billion]
Eisai Company Limited
(547.92 billion Japanese Yen [US$4.87 billion]
of which 49%
was Pharmaceutical Business -Japan).
During the year ended March of 2016, sales at
Mitsubishi Tanabe Pharma Corp were ¥431.70 billion (US$3.83 billion).
increase of 4.0%
versus 2015, when the company's sales were ¥415.12 billion.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Mitsubishi Tanabe Pharma Corp had sales
of ¥409.54 billion.
Sales of Pharmaceutical Products saw an increase
4.0% in 2016, from
¥414.69 billion to ¥431.32 billion.
Not all segments of Mitsubishi Tanabe Pharma Corp experienced an increase in sales in 2016:
sales of Other fell 13.5% to ¥379.00 million.
(However, this segment's sales were only a very small portion of the company's overall sales).